Loading company details...
Beta
Latest Form 4 (Oct 13, 2026): Tiffany Eul Davis Inglis (Chief Medical Officer): Sale of 8,024 shares, $16.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Tiffany Eul Davis Inglis, Chief Medical Officer | Sale | 8,024 | $16.3K |
| Sep 11, 2026 | Dyaarl Lee Anderson Jr., Chief Commercial Officer | Sale | 1,800 | $3.6K |
| Sep 11, 2026 | Zhenya Lindgardt, Chief Executive Officer | Sale | 7,022 | $14.0K |
| Sep 11, 2026 | Tiffany Eul Davis Inglis, Chief Medical Officer | Sale | 486 | $972.00 |
| Sep 11, 2026 | Benjamin Jackson, General Counsel | Sale | 2,190 | $4.4K |
| Sep 9, 2026 | Zhenya Lindgardt, Chief Executive Officer | Sale | 20,139 | $40.3K |
| Sep 1, 2026 | Scott Gleason, Chief Financial Officer | Grant/Award | 117,924 | n/a |
| Jul 14, 2026 | Joshua Phillips | Grant/Award | 22,426 | n/a |
| Jul 14, 2026 | Mansoor Raza Mirza | Grant/Award | 22,426 | n/a |
| Jul 14, 2026 | Sandra Aj Lawrence | Grant/Award | 22,426 | n/a |